Intended for healthcare professionals

Letters Agreement on branded drugs

NHS spending on branded drugs has been capped

BMJ 2019; 365 doi: (Published 23 April 2019) Cite this as: BMJ 2019;365:l1393
  1. Richard Torbett, executive director of commercial policy
  1. Association of the British Pharmaceutical Industry, London SW1E 6QT, UK
  1. rtorbett{at}

Naci and Dixon discuss the new voluntary scheme for branded drugs.1 But the claim that NHS spending on drugs has been rising sharply is not entirely accurate. It is true in some areas, such as in specialised medicines where the increase is because of a wave of new treatment options. But overall, NHS spending on branded drugs has been capped …

View Full Text

Log in

Log in through your institution


* For online subscription